Building Precision Cancer Research Capacity in Virgin Islands
GrantID: 14993
Grant Funding Amount Low: $720,000
Deadline: Ongoing
Grant Amount High: $720,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Health & Medical grants, Research & Evaluation grants, Science, Technology Research & Development grants.
Grant Overview
Grant Overview for the Virgin Islands
State Fit for Precision Cancer Prevention Research
The Virgin Islands is a unique and strategic location for advancing collaborative research on precision cancer prevention and interception. As a U.S. territory situated in the Caribbean, the Virgin Islands offers a distinct regional context and population profile that can yield valuable insights to complement and enhance national efforts in this critical domain of public health.
Distinct Regional Context
The Virgin Islands' geographic positioning in the Caribbean basin sets it apart from many of its mainland U.S. counterparts. As a small island territory, it faces distinct socioeconomic, infrastructure, and environmental challenges that shape the cancer landscape. For example, the territory's reliance on imported goods and services, limited healthcare resources, and vulnerability to natural disasters can exacerbate barriers to early detection, preventive care, and continuity of treatment.
Additionally, the Virgin Islands' diverse population, which includes significant African American, Afro-Caribbean, and Hispanic/Latino communities, presents an opportunity to better understand how genetic, behavioral, and cultural factors intersect to influence cancer risk and outcomes in underrepresented minority groups. This regional diversity aligns with the grant's focus on precision medicine, as it can inform the development of more tailored, equitable interventions.
The Territory's Unique Cancer Burden
Cancer is a significant public health concern in the Virgin Islands, with certain types disproportionately impacting the local population. For example, prostate cancer incidence and mortality rates are notably higher in the territory compared to national averages, likely due to a combination of genetic, lifestyle, and access-to-care factors. Breast cancer also presents a substantial burden, with higher-than-average mortality rates, potentially linked to barriers to early detection and timely treatment.
These regional disparities in cancer outcomes underscore the need for targeted, community-engaged research to develop precision-focused interventions that address the unique vulnerabilities of the Virgin Islands' population. By leveraging its distinct regional context, the territory can contribute valuable insights to national efforts in precision cancer prevention and interception.
Capacity and Readiness
The Virgin Islands possesses a range of assets and capabilities that position it well to participate in the proposed grant program. The territory is home to the only public university system, the University of the Virgin Islands (UVI), which houses several research centers and institutes focused on health, environmental, and social issues.
UVI's Center for Excellence in Leadership and Learning (CELL) has a strong track record of community-engaged research and has cultivated partnerships with local healthcare providers, government agencies, and community organizations. This existing collaborative infrastructure can facilitate the development of a robust research network to tackle the challenges of precision cancer prevention.
Additionally, the territory's relatively small size and close-knit communities offer advantages in implementing and evaluating precision-focused interventions. The Virgin Islands' healthcare system, while limited in resources, has demonstrated agility in responding to public health emergencies, which can translate to the nimble deployment of new cancer prevention and early detection initiatives.
However, the Virgin Islands also faces significant capacity constraints that must be addressed to fully leverage its potential. Limited funding, a shortage of specialized healthcare providers, and aging technological infrastructure are some of the key challenges that may impede the territory's ability to conduct and sustain complex, collaborative research efforts. Addressing these gaps through strategic investments and capacity-building initiatives will be crucial for the Virgin Islands to serve as an effective partner in the proposed grant program.
Implementation and Timeline
Applicants from the Virgin Islands seeking to participate in the grant program should be prepared to navigate a multifaceted implementation process. The Virgin Islands Department of Health, in partnership with UVI and other key stakeholders, will play a central role in coordinating the development and execution of the research proposal.
The application process will require a robust community engagement strategy to ensure that the research aligns with the needs and priorities of the local population. Establishing strong collaborations with community-based organizations, healthcare providers, and other relevant partners will be essential for securing buy-in and facilitating the implementation of interventions.
The timeline for the grant program will likely involve several phases, including a planning and design period, followed by a multi-year implementation phase. Applicants should be prepared to demonstrate a clear, well-structured plan for project management, data collection, and evaluation to ensure the timely and effective delivery of outcomes.
Priority Outcomes and Significance
The proposed grant program's focus on precision cancer prevention and interception holds significant relevance and importance for the Virgin Islands. By addressing the territory's unique cancer burden and leveraging its distinct regional context, the research undertaken through this initiative can yield transformative outcomes, including:
- Improved understanding of the genetic, behavioral, and environmental factors that contribute to cancer disparities in the Virgin Islands' diverse population.
- Development of tailored, community-centered interventions that enhance early detection, preventive care, and access to cutting-edge treatment options.
- Strengthened collaborative research infrastructure and capacity within the territory, fostering long-term sustainability and the ability to address other pressing public health challenges.
These priority outcomes align with the Virgin Islands' strategic health and wellness goals, and their realization can have far-reaching implications for improving cancer outcomes and promoting health equity in the territory and beyond.
Risk and Compliance Considerations
Applicants from the Virgin Islands should be aware of several key risk and compliance factors that may impact their participation in the grant program:
- Eligibility Barriers: The territory's unique status as a U.S. possession may introduce administrative or regulatory hurdles that require careful navigation to ensure full eligibility and compliance with the grant's requirements.
- Data Governance and Privacy: The Virgin Islands' small population and close-knit communities necessitate robust data governance protocols to protect the privacy and confidentiality of research participants, particularly in the context of precision medicine initiatives.
- Infrastructure and Logistics: The territory's geographical isolation, limited resources, and vulnerability to natural disasters may pose logistical challenges in areas such as equipment procurement, sample transportation, and the reliable delivery of interventions.
Addressing these risk factors through proactive planning, strategic partnerships, and the leveraging of existing institutional and governmental frameworks will be crucial for Virgin Islands applicants to successfully participate in the grant program and achieve the desired outcomes.
FAQs for Virgin Islands Applicants
Q: What are the key advantages the Virgin Islands offers for precision cancer prevention research? A: The Virgin Islands' unique regional context, diverse population, and existing research infrastructure provide distinct advantages for precision cancer prevention research. The territory's geographic positioning, healthcare landscape, and vulnerable communities present opportunities to generate insights that can complement national efforts and address disparities in underrepresented groups.
Q: How can the Virgin Islands address its capacity constraints to effectively participate in the grant program? A: To address capacity constraints, the Virgin Islands will need to leverage strategic partnerships, secure additional funding, and invest in infrastructure and workforce development. Collaborations with mainland U.S. institutions, government agencies, and community organizations can help strengthen research capabilities, access specialized expertise, and overcome resource limitations.
Q: What are the critical compliance and risk factors that Virgin Islands applicants should consider when applying for the grant? A: Virgin Islands applicants should be aware of potential eligibility barriers due to the territory's unique status, the need for robust data governance and privacy protocols, and logistical challenges posed by the territory's geographical isolation and vulnerability to natural disasters. Proactive planning and the leveraging of existing institutional and governmental frameworks will be crucial to mitigate these risks and ensure successful participation in the grant program.
Eligible Regions
Interests
Eligible Requirements
Related Grants
Grants for Cooperative Agreement Applications for Investigator-Initiated Mid-Phase Clinical Trials of Natural Products
Grants for cooperative agreement applications for Investigator-Initiated Mid-Phase Clinical Trials o...
TGP Grant ID:
13907
Career Development for Substance Use Prevention Grant
Invites and provides an opportunity for early career researchers or early career clinicians with fou...
TGP Grant ID:
22277
Grants to Support Dancers in Need
Grant offers a lifeline to professional dancers facing dire financial circumstances, providing one-t...
TGP Grant ID:
63299
Grants for Cooperative Agreement Applications for Investigator-Initiated Mid-Phase Clinical Trials o...
Deadline :
2099-12-31
Funding Amount:
$0
Grants for cooperative agreement applications for Investigator-Initiated Mid-Phase Clinical Trials of Natural Products. Application budgets are n...
TGP Grant ID:
13907
Career Development for Substance Use Prevention Grant
Deadline :
2025-11-12
Funding Amount:
$0
Invites and provides an opportunity for early career researchers or early career clinicians with foundational backgrounds in addiction to develop expe...
TGP Grant ID:
22277
Grants to Support Dancers in Need
Deadline :
2024-05-17
Funding Amount:
$0
Grant offers a lifeline to professional dancers facing dire financial circumstances, providing one-time grants of up to $3,000. The grant aims to alle...
TGP Grant ID:
63299